| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |